One size does not fit all: uncontrolled T2 inflammation on tezepelumab-a case series. [PDF]
Allergy Asthma Clin ImmunolTardif A +3 more
europepmc +1 more source
Rebuilding the Mucociliary Apparatus in ECRS: TSLP/IL-33 Signaling Synergy and the Residual Molecular Scar of <i>DNASE1L3</i> Following IL-4/13 Blockade. [PDF]
CellsFujita R +10 more
europepmc +1 more source
Eosinophil-Epithelial Cell Crosstalk at Mucosal Barriers: From Homeostatic Regulation to Disease Pathogenesis. [PDF]
CellsLee J, Kim E.
europepmc +1 more source
The predictive value of combined detection of serum IL-33, TSLP and eosinophils in the treatment effect and exacerbation risk of chronic obstructive pulmonary disease. [PDF]
BMC Pulm MedXu J, Wang Y, Gu H, Chen X.
europepmc +1 more source
Dupilumab attenuates the expression of TSLP and IL-8 induced by dsRNA and IL-4/IL-13 co-stimulation in human small airway epithelial cells. [PDF]
PLoS OneSri Listyoko A +8 more
europepmc +1 more source
An Ex Vivo Model of Post Infectious Bronchiolitis Obliterans in Children Using Reconstituted Human Bronchial Epithelium. [PDF]
BiomoleculesMazenq J +7 more
europepmc +1 more source
Targeting the Epithelial Alarmin Axis with Biomedical Nanoparticles: A New Frontier in Allergic Asthma Therapy. [PDF]
Int J NanomedicineYang Y.
europepmc +1 more source
Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. [PDF]
PLoS OneSegawa R +3 more
europepmc +1 more source
The evaluation of the plasma levels of interleukin 17A, thymic stromal lymphopoietin, interferon gamma, tumor necrosis factor-alpha and interleukins IL-2, IL-6, IL-23, and IL-31 in atopic dermatitis patients with dupilumab treatment. [PDF]
Front ImmunolČelakovská J +3 more
europepmc +1 more source